Earlier this year, I wrote about a draft academic paper that had attempted to condemn the new NICE guideline for ME/CFS. As regular readers might recall, the paper had claimed that NICE was guilty of “eight major errors” in its guideline reviewing processes. In my blog post I noted that […]
Colleagues and I have responded to a paper in Der Nervenarzt, the leading German neurology journal, pointing out various reasons why its “overview” of evidence-based approaches to ME/CFS treatment lacked, well, evidence. Our critique can be read in full in English via the following Tweet (kudos to @AnilvanderZee): In summary, […]
“No one comes up here without a damn good reason.” * * * Regular readers will recall that I have previously written about the UK’s new healthcare guidelines for ME/CFS, as published by the National Institute for Health and Care Excellence (NICE) in 2021. Whereas the old guidance had proposed […]
Here is a transcript of my recent podcast with the Norwegian ME Association. In the interview, we discuss the medical stigma where post-viral illnesses, such as ME and Long COVID, are falsely characterised as ‘psychological’ due to poorly grounded stereotyping. The discussion touches on how medical opinion has become intertwined […]
I recently had the pleasure of talking with the folks at the Norwegian ME Association for their (excellently produced) podcast series. Arising from my new book, we discussed the medical stigma in which an illness is falsely characterised as ‘psychological’ — post-viral conditions such as ME and Long Covid, for […]
Just the other week, I spoke at the annual conference of the RME, the Swedish National Association for ME. In my lecture, I took another look at the new ME/CFS guideline as published by NICE about one year ago. While I covered ground that might be familiar to some, it […]
